Hong Kong Stock Movement | CHINA AEROSPACE (00031) Surges Over 11% Intraday as H1 Revenue Grows More Than 10% with Further Technology Industrial Business Capacity Expansion

Stock News
09/03

CHINA AEROSPACE (00031) surged over 11% during trading, and as of press time, the stock was up 8.33% to HK$0.65 with a turnover of HK$21.692 million.

On the news front, CHINA AEROSPACE previously announced its interim results, with revenue of approximately HK$2.023 billion, representing a year-on-year increase of 10.89%. However, the loss attributable to shareholders of the company expanded by 48.15% to HK$42.337 million.

During the period, the injection molding products business recorded revenue growth of 20.32% compared to the same period last year, driving up the overall operating profit of the technology industrial segment. The PCB business overall sales stabilized with revenue increasing 11.42% year-on-year, mainly driven by strong growth in optoelectronic modules and domestic substrate business.

Notably, CHINA AEROSPACE disclosed in its interim financial report that the civil engineering of the Nantong Kangyuan integrated circuit packaging substrate capacity construction project has been completed, with production line construction proceeding in an orderly manner and small-batch trial operations expected to begin in the first half of 2025. The IPM packaging business officially commenced production at the beginning of the year, with some products achieving domestic substitution. Leveraging the business demand brought by domestic enterprises establishing factories in Vietnam, the Vietnam Zhiyuan injection molding business has reached full capacity and is planning the construction of a phase 2 project.

These new capacity constructions are expected to increase the company's overall production capacity by approximately 40%, providing assurance for enhancing revenue scale and quality.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10